Rezultati
еНаука >
Резултати >
Lighthouse: melflufen, daratumumab, and dexamethasone versus daratumumab in relapsed/refractory multiple myeloma refractory to an imid and a proteasome inhibitor or with ≥3 prior lines of therapy
| Title: | Lighthouse: melflufen, daratumumab, and dexamethasone versus daratumumab in relapsed/refractory multiple myeloma refractory to an imid and a proteasome inhibitor or with ≥3 prior lines of therapy | Authors: | Mateos, Maria-Victoria; Szarejko, Monika; Bila, Jelena S.   ; Schjesvold, Fredrik; Spicka, Ivan; Maisnar, Vladimir; Jurczyszyn, Artur; Grudeva-Popova, Zhanet; Hajek, Roman; Usenko, Hanna; |
Issue Date: | 2023 | Publication: | Clinical lymphoma, myeloma & leukemia (The Abstract from International Myeloma Society 20th Annual Meeting and Exposition, 27-30 September 2023, Athens, Greece) | ISSN: | 2152-2650 Clinical Lymphoma Myeloma and Leukemia Search Idenfier |
Publisher: | [New York] : Elsevier | Type: | Conference Paper | Collation: | vol. 23 br. Suppl 2 str. S200-S201 | DOI: | 10.1016/S2152-2650(23)01914-6 | WoS-ID: | 001079705400348 | URI: | https://enauka.gov.rs/handle/123456789/934852 | URL: | https://www.sciencedirect.com/science/article/abs/pii/S2152265023019146 | Metadata source: | (Preuzeto iz Nasi u WoS) | M-category: | Mp. category will be shown later |
Rezultati na eNauka su zaštićeni autorskim pravima i sva prava su zadržana, osim ako nije drugačije naznačeno.